Pages that link to "Q28246002"
Jump to navigation
Jump to search
The following pages link to Pharmacogenetics in inflammatory bowel disease (Q28246002):
Displaying 13 items.
- Prevalence and outcome of anemia after restorative proctocolectomy: a clinical literature review (Q33436622) (← links)
- Glucocorticoid receptor gene haplotype structure and steroid therapy outcome in IBD patients (Q34073595) (← links)
- TNFAIP3 gene polymorphisms are associated with response to TNF blockade in psoriasis (Q35754087) (← links)
- Microfluidic platform for single nucleotide polymorphism genotyping of the thiopurine S-methyltransferase gene to evaluate risk for adverse drug events (Q35988128) (← links)
- Treatment of inflammatory bowel disease: a review of medical therapy (Q37058862) (← links)
- Gene polymorphisms and pharmacogenetics in rheumatoid arthritis (Q37214931) (← links)
- Colon-targeted delivery of live bacterial cell biotherapeutics including microencapsulated live bacterial cells. (Q37290683) (← links)
- IL-10 and TNF-alpha promoter haplotypes are associated with childhood Crohn's disease location (Q37304245) (← links)
- Efficacy of 6-mercaptopurine treatment after azathioprine hypersensitivity in inflammatory bowel disease (Q37316667) (← links)
- Changes in liver biochemistry during methotrexate use for inflammatory bowel disease (Q37693666) (← links)
- Thiopurine S-methyltransferase polymorphisms and thiopurine toxicity in treatment of inflammatory bowel disease (Q37769185) (← links)
- Distribution of TPMT risk alleles for thiopurine [correction of thioupurine] toxicity in the Israeli population (Q46219969) (← links)
- Using genetic information for the identification, classification and treatment of Crohn’s disease: are we there yet? (Q56968849) (← links)